Abstract:Hypoxia is a hallmark of solid tumors. Hypoxic cancer cells adjust their metabolic characteristics to regulate the production of cellular reactive oxygen species (ROS) and facilitate ROS‐mediated metastasis. Peroxisome proliferator‐activated receptor γ (PPARγ) is a nuclear receptor that regulates the transcription of fatty acid metabolism‐related genes that have a key role in the survival and proliferation function of hypoxic cancer cells. In the present study, mRNA expression in HepG2 cells under chemically induced hypoxia was assessed. The protein expression levels of hypoxia‐inducible factor 1α (HIF‐1α) were measured using western blotting. Following treatment with the PPARγ agonist pioglitazone, cell viability was assessed using a Cell Counting Kit‐8 assay, whilst cell proliferation and death were determined using 5‐ethynyl‐2'‐deoxyuridine incorporation staining, and calcein‐acetoxymethyl ester and propidium iodide staining, respectively. Cellular ROS production was assessed using dihydroethidium staining. Cobalt chloride was used to induce hypoxia in HepG2 cells, which was evaluated using HIF‐1α expression. The results revealed that the mRNA expression of PPARγ, CD36, acetyl‐co‐enzyme A dehydrogenase (ACAD) medium chain (ACADM) and ACAD short‐chain (ACADS) was downregulated in hypoxic HepG2 cells. The PPARγ agonist pioglitazone decreased the cell viability of hypoxic HepG2 cells by inhibiting cell proliferation and inducing cell death. Following treatment with the PPARγ agonist pioglitazone, hypoxic HepG2 cells produced excessive ROS. ROS‐mediated cell death induced by the PPARγ agonist pioglitazone was rescued with the antioxidant N‐acetyl‐L‐cysteine. The downregulated mRNA expression of PPARγ, CD36, ACADM and ACADS was not reverted by a PPARγ agonist in hypoxic HepG2 cells. By contrast, the PPARγ agonist suppressed the mRNA expression of BCL2, which was upregulated in hypoxic HepG2 cells. In summary, the PPARγ agonist stimulated excessive ROS production to inhibit cell proliferation and increase the death of hypoxic HepG2 cells by decreasing BCL2 mRNA expression, suggesting a negative association between PPARγ and BCL2 in the regulation of ROS production in hypoxic HepG2 cells.

Peroxisome proliferator-activated receptor γ agonist pioglitazone inhibits glioma cell growth mediated by β-catenin

Poster Session AP2: Cell Death and Survival

Effect and Mechanism of Pioglitazone on Cell Growth in Human Gastric Cancer Cells

Potential Therapeutic Effects of Thiazolidinedione on Malignant Glioma

The Inhibition of the Breast Cancer by PPARγ Agonist Pioglitazone Through JAK2/STAT3 Pathway.

Effects of pioglitazone on proliferation,apoptosis and function of endothelial progenitor cells

Pioglitazone, a PPARγ agonist, inhibits growth and invasion of human hepatocellular carcinoma via blockade of the rage signaling

Peroxisome Proliferator-Activated Receptor Γ Ligands Induce Apoptosis of Renal Cell Carcinoma

Lobeglitazone, A Peroxisome Proliferator-Activated Receptor-Gamma Agonist, Inhibits Papillary Thyroid Cancer Cell Migration and Invasion by Suppressing p38 MAPK Signaling Pathway

[Effects of Peroxisome Proliferator-Activated Receptor-Gamma Ligand Troglitazone on Colon Cancer Cell Growth].

Pioglitazone, a peroxisome proliferator‐activated receptor γ agonist, induces cell death and inhibits the proliferation of hypoxic HepG2 cells by promoting excessive production of reactive oxygen species

Effects and Mechanisms of Pioglitazone on Migration of Rat,s Bone Marrow Drived Endothelial Progenitor Cells

The Analgesic Effects of Pioglitazone in the Bone Cancer Pain Rats Via Regulating the PPARγ/PTEN/mTOR Signaling Pathway in the Spinal Dorsal Horn.

Terminal differentiation into adipocyte and growth inhibition by PPARγ activation in human A549 lung adenocarcinoma cells

Inhibitory Effect of Pioglitazone on TGF-β1 Gene Expression in Renal Cortex of Diabetic Rats

Peroxisome Proliferator-Activated Receptor Γ Ligands Induce Cell Cycle Arrest and Apoptosis in Human Renal Carcinoma Cell Lines

[Peroxisome Proliferator-Actived Receptor-Gamma Ligand Troglitazone Induces Apoptosis in Renal Cell Carcinoma].

Genistin Represses the Proliferation and Angiogenesis While Accelerating the Apoptosis of Glioma Cells by Modulating the FOXC1-Mediated Wnt Signaling Pathway

Pioglitazone mediates apoptosis in Caki cells via downregulating c-FLIP(L) expression and reducing Bcl-2 protein stability

Gambogenic acid-induced time- and dose-dependent growth inhibition and apoptosis involving Akt pathway inactivation in U251 glioblastoma cells

Up-Regulation Of Mir-221 Mediates The Pioglitazone-Induced Inhibition Of Vascular Endothelial Cell Proliferation